Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor subtype γ (PPARγ) activators that are clinically used as an insulin sensitizer for glycemic control in patients with type 2 diabetes. Additionally, TZDs exhibit novel anti-inflammatory, antioxidant, and antiproliferative proper...
Saved in:
Main Authors: | Tianxin Yang, Sunhapas Soodvilai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/943614 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
by: Jerzy Bełtowski, et al.
Published: (2013-01-01) -
Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
by: Shoko Horita, et al.
Published: (2015-01-01) -
Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease
by: María José Pérez, et al.
Published: (2015-01-01) -
Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01) -
Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
by: Wei Wei, et al.
Published: (2011-01-01)